venlafaxin "orion" 37,5 mg depotkapsler, hårde
orion corporation - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg
venlafaxin "orion" 75 mg depotkapsler, hårde
orion corporation - venlafaxinhydrochlorid - depotkapsler, hårde - 75 mg
venlafaxin "stada" 150 mg depotkapsler, hårde
stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 150 mg
venlafaxin "stada" 37,5 mg depotkapsler, hårde
stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg
venlafaxin "stada" 75 mg depotkapsler, hårde
stada arzneimittel ag - venlafaxinhydrochlorid - depotkapsler, hårde - 75 mg
venlafaxin "medical valley" 300 mg depottabletter
medical valley invest ab - venlafaxinhydrochlorid - depottabletter - 300 mg
venlafaxin "nordic prime" 75 mg depotkapsler, hårde
nordic prime aps - venlafaxinhydrochlorid - depotkapsler, hårde - 75 mg
venlafaxin "paranova" 37,5 mg depotkapsler, hårde
paranova danmark a/s - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg
daurismo
pfizer europe ma eeig - glasdegib maleate - leukæmi, myeloid, akut - antineoplastiske midler - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.
venlafaxin "nordic prime" 37,5 mg depotkapsler, hårde
nordic prime aps - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg